Pharma Pulse: Infinitus' AI Hub Play, EVERSANA's Cell Therapy Partnership, Cold Chain Deals
Jul 30, 02:49 PM
Share
Subscribe
In this week's Pharma Pulse, Infinitus launches an AI-first hub model, EVERSANA is tapped to commercialize Innovacell's regenerative cell therapy in the US, Peli BioThermal and PAXAFE pair packaging with predictive cold chain intelligence, and Ember LifeSciences strikes a distribution alliance with Japan's top pharma wholesaler.
